Wilson David Ian

USNatural personDirector

Insider

Wilson David Ian

USNatural personDirector

Transactions

Issuers

Buys / Sells

0/0

Last tx

20 Jan 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Neuphoria Therapeutics Inc.	15,412	reported	20 Jan 2026	tx 2+15,320

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
20 Jan 2026	GRANT_AWARD	Neuphoria Therapeutics Inc.	8,537	0.00 USD	deriv
16 Apr 2025	GRANT_AWARD	Neuphoria Therapeutics Inc.	6,783	0.00 USD	deriv

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Neuphoria Therapeutics Inc.	15,412	reported	20 Jan 2026	tx 2+15,320

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
20 Jan 2026	GRANT_AWARD	Neuphoria Therapeutics Inc.	8,537	0.00 USD	deriv
16 Apr 2025	GRANT_AWARD	Neuphoria Therapeutics Inc.	6,783	0.00 USD	deriv